The McCain GU BioBank is an investigator-initiated biobanking program that collects and archives biological specimens and data obtained from consenting urologic oncology patients to facilitate the discovery and validation of novel biomarkers, aiming to achieve personalized medicine in Urology.

Strategic Research Initiatives Development
Overview

Under the leadership of Dr. Neil Fleshner, The McCain GU BioBank is a central resource which houses annotated and high quality blood and urine specimens obtained from consenting patients who have attended out-patient clinics within the Genito Urinary (GU) division for the suspicion, diagnosis and/or treatment of a GU tumor (Prostate, Kidney, Bladder, Testis, Penis). These archived specimens are used in future research studies that aim to increase our understanding of urologic diseases (in particular cancer) and discover new ways of diagnosing and managing disease.
Services & Unique Capabilities
a)    Provision of retrospectively collected specimens (plasma, serum, buffy coat, urine) and/or data for REB-approved research
b)    Prospective collection services 
c)    Study-directed banking services
d)    Protocol and SOP development services
Using the Facility

For Services a through c listed in the 'Services and Unique Capabilities section', simply submit your request via the CAPCR system at UHN. For all other services or inquiries, contact the McCain BioBank Manager directly (Heidi Wagner @heidi.wagner@uhn.ca). Note, an executed Materials Transfer Agreement is required for all external collaborations. Please inquire regarding applicable fees for the service of interest. 
Contacts

Heidi Wagner, BSc., PA
Clinical Research Manager
Prostate and Uro-Oncology Clinical Research Unit
Princess Margaret Cancer Centre
700 University Ave., 2nd Floor, North
Toronto, ON M5G 1Z5
Tel. 416-946-4501 x 2354  I  Fax. 416-946-2180
Core Facilities & Innovation

The McCain GU BioBank is an investigator-initiated biobanking program that collects and archives biological specimens and data obtained from consenting urologic oncology patients to facilitate the discovery and validation of novel biomarkers, aiming to achieve personalized medicine in Urology.

Contacts

Heidi Wagner, BSc., PA
Clinical Research Manager
Prostate and Uro-Oncology Clinical Research Unit
Princess Margaret Cancer Centre
700 University Ave., 2nd Floor, North
Toronto, ON M5G 1Z5
Tel. 416-946-4501 x 2354  I  Fax. 416-946-2180
Overview

Under the leadership of Dr. Neil Fleshner, The McCain GU BioBank is a central resource which houses annotated and high quality blood and urine specimens obtained from consenting patients who have attended out-patient clinics within the Genito Urinary (GU) division for the suspicion, diagnosis and/or treatment of a GU tumor (Prostate, Kidney, Bladder, Testis, Penis). These archived specimens are used in future research studies that aim to increase our understanding of urologic diseases (in particular cancer) and discover new ways of diagnosing and managing disease.
Services & Unique Capabilities
a)    Provision of retrospectively collected specimens (plasma, serum, buffy coat, urine) and/or data for REB-approved research
b)    Prospective collection services 
c)    Study-directed banking services
d)    Protocol and SOP development services
Using the Facility

For Services a through c listed in the 'Services and Unique Capabilities section', simply submit your request via the CAPCR system at UHN. For all other services or inquiries, contact the McCain BioBank Manager directly (Heidi Wagner @heidi.wagner@uhn.ca). Note, an executed Materials Transfer Agreement is required for all external collaborations. Please inquire regarding applicable fees for the service of interest.